{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T21:23:03Z","timestamp":1787865783546,"version":"build-2784847793"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Safety data on tetracycline antibiotic use during pregnancy are limited.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To investigate the association between first trimester exposure to tetracyclines and the risk of major congenital malformations (MCMs).<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This cohort study used data from nationwide registers for singleton infants live-born in Sweden from July 1, 2006, to December 31, 2018, with follow-up through December 2019. Tetracycline-exposed and unexposed infants were matched on propensity scores (ratio 1:10). Data analysis was performed from June 2023 to May 2024.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n First trimester exposure to tetracyclines determined from maternal prescription fills, compared with no exposure.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n \n The primary outcome was any MCM diagnosed in the first year of life; secondary outcomes were 12 major malformation organ system subgroups and 16 individual malformations selected on the basis of prior safety signals and\/or fulfillment of prespecified statistical power criteria. Malformations were identified by\n International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10)<\/jats:italic>\n codes aligned to the European Surveillance of Congenital Anomalies (EUROCAT) classification. Log binomial regression was used to estimate relative risks (RRs) with 95% CIs.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n From a source cohort of 1\u202f245\u202f889 eligible infants (640 892 male [51.4%]), a propensity score\u2013matched analytical cohort of 69\u202f656 infants (35\u202f903 male [51.5%]) was generated. Of 6340 infants exposed to tetracyclines during the first trimester (3325 male [52.4%]), 252 received a diagnosis of any MCM (39.75 cases per 1000 infants; 95% CI, 35.14-44.93 cases per 1000 infants) compared with 2454 of 63\u202f316 unexposed infants (38.76 cases per 1000 infants; 95% CI, 37.27-40.30 cases per 1000 infants). Tetracycline exposure was not associated with any MCM (RR, 1.03; 95% CI, 0.90-1.16). The RRs for specific tetracycline substances were 1.07 (95% CI, 0.93-1.23) for doxycycline, 0.83 (95% CI, 0.60-1.15) for lymecycline, and 0.78 (95% CI, 0.32-1.92) for tetracycline-oxytetracycline. There was no increased risk for 10 of 12 malformation subgroups or for any of the 16 individual malformations analyzed. The higher RRs in the main analysis for nervous system anomalies (1.92; 95% CI, 0.98-3.78) and eye anomalies (1.76; 95% CI, 1.07-2.91) were attenuated in a sensitivity analysis with follow-up extended to age 3 years (nervous system anomalies, RR, 1.08; 95% CI, 0.52-2.24; eye anomalies, RR, 1.42; 95% CI, 0.88-2.29).<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cohort study, first trimester tetracycline exposure was not associated with increased risks of any MCMs. Additional studies are needed to rule out potential risks owing to power limitations for several MCM subgroups and individual malformations.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.45055","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T11:00:54Z","timestamp":1731582054000},"page":"e2445055","source":"Crossref","is-referenced-by-count":12,"title":["First Trimester Tetracycline Exposure and Risk of Major Congenital Malformations"],"prefix":"10.1001","volume":"7","author":[{"given":"Aya Olivia","family":"Nakitanda","sequence":"first","affiliation":[{"name":"Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingvild","family":"Odsbu","sequence":"additional","affiliation":[{"name":"Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn E.","family":"Cesta","sequence":"additional","affiliation":[{"name":"Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pazzagli","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Pasternak","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"issue":"12","key":"zoi241286r1","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.3390\/pharmaceutics13122085","article-title":"The development of third-generation tetracycline antibiotics and new perspectives.","volume":"13","author":"Rusu","year":"2021","journal-title":"Pharmaceutics"},{"issue":"3","key":"zoi241286r3","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/aogs.14741","article-title":"Antibiotic use during pregnancy in Sweden: a nationwide utilization study covering 2007-2019.","volume":"103","author":"Nakitanda","year":"2024","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"12","key":"zoi241286r4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-050569","article-title":"Use of interrupted time-series analysis to characterise antibiotic prescription fills across pregnancy: a Norwegian nationwide cohort study.","volume":"11","author":"Trinh","year":"2021","journal-title":"BMJ Open"},{"issue":"6","key":"zoi241286r5","doi-asserted-by":"publisher","first-page":"648.e1","DOI":"10.1016\/j.ajog.2019.06.050","article-title":"In utero exposure to antibiotics and risk of congenital malformations: a population-based study.","volume":"221","author":"Damkier","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"zoi241286r6","doi-asserted-by":"publisher","first-page":"250.e1","DOI":"10.1016\/j.ajog.2023.12.020","article-title":"Prescription medication use during pregnancy in the United States from 2011 to 2020: trends and safety evidence.","volume":"231","author":"Mansour","year":"2024","journal-title":"Am J Obstet Gynecol"},{"issue":"17","key":"zoi241286r7","first-page":"849","article-title":"Effects of tetracyclines on skeletal growth and dentition: a report by the Nutrition Committee of the Canadian Paediatric Society.","volume":"99","author":"Demers","year":"1968","journal-title":"CMAJ"},{"issue":"1","key":"zoi241286r8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00404-020-05569-4","article-title":"Association of antibiotics therapy during pregnancy with spontaneous miscarriage: a systematic review and meta-analysis.","volume":"302","author":"Omranipoor","year":"2020","journal-title":"Arch Gynecol Obstet"},{"issue":"70","key":"zoi241286r9","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1093\/cid\/ciz1231","article-title":"Safety of antimicrobials during pregnancy: a systematic review of antimicrobials considered for treatment and postexposure prophylaxis of plague.","volume":"70","author":"Yu","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"zoi241286r10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1517\/14740338.2016.1133584","article-title":"Revisiting doxycycline in pregnancy and early childhood\u2014time to rebuild its reputation?","volume":"15","author":"Cross","year":"2016","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"zoi241286r11","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1597\/05-208.1","article-title":"Drug treatment during pregnancy and isolated orofacial clefts in Hungary.","volume":"44","author":"Puh\u00f3","year":"2007","journal-title":"Cleft Palate Craniofac J"},{"issue":"1","key":"zoi241286r12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0301-2115(99)00112-8","article-title":"A population-based case-control teratologic study of oral oxytetracycline treatment during pregnancy.","volume":"88","author":"Czeizel","year":"2000","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"zoi241286r13","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0029-7844(97)00005-7","article-title":"Teratogenic study of doxycycline.","volume":"89","author":"Czeizel","year":"1997","journal-title":"Obstet Gynecol"},{"issue":"1","key":"zoi241286r14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1365-3016.2008.00978.x","article-title":"Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations.","volume":"23","author":"Cooper","year":"2009","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"11","key":"zoi241286r15","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1111\/bcp.13364","article-title":"Use of antibiotics during pregnancy and the risk of major congenital malformations: a population based cohort study.","volume":"83","author":"Muanda","year":"2017","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"zoi241286r16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/pds.2179","article-title":"Maternal use of antibiotics and the risk of orofacial clefts: a nationwide cohort study.","volume":"21","author":"M\u00f8lgaard-Nielsen","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"11","key":"zoi241286r17","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1001\/archpediatrics.2009.188","article-title":"Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study.","volume":"163","author":"Crider","year":"2009","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"1","key":"zoi241286r18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10654-022-00947-5","article-title":"The Swedish medical birth register during five decades: documentation of the content and quality of the register.","volume":"38","author":"Cnattingius","year":"2023","journal-title":"Eur J Epidemiol"},{"issue":"7","key":"zoi241286r19","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register\u2014opportunities for pharmacoepidemiological research and experience from the first six months.","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"zoi241286r22","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register.","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"issue":"9","key":"zoi241286r23","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10654-017-0316-1","article-title":"The Swedish cause of death register.","volume":"32","author":"Brooke","year":"2017","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"zoi241286r25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40471-017-0131-y","article-title":"Propensity scores in pharmacoepidemiology: beyond the horizon.","volume":"4","author":"Jackson","year":"2017","journal-title":"Curr Epidemiol Rep"},{"key":"zoi241286r26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.annepidem.2023.08.001","article-title":"Calculating risk and prevalence ratios and differences in R: developing intuition with a hands-on tutorial and code.","volume":"86","author":"Yorlets","year":"2023","journal-title":"Ann Epidemiol"},{"issue":"1","key":"zoi241286r27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","article-title":"No adjustments are needed for multiple comparisons.","volume":"1","author":"Rothman","year":"1990","journal-title":"Epidemiology"},{"issue":"6","key":"zoi241286r29","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/ppe.13011","article-title":"Detection of major congenital malformations depends on length of follow-up in Swedish National Health Register Data: implications for pharmacoepidemiological research on medication safety in pregnancy.","volume":"38","author":"Segovia Chac\u00f3n","year":"2024","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"7","key":"zoi241286r30","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s40264-023-01307-2","article-title":"Prenatal exposure to pregabalin, birth outcomes and neurodevelopment: a population-based cohort study in four Nordic countries.","volume":"46","author":"Dudukina","year":"2023","journal-title":"Drug Saf"},{"issue":"17","key":"zoi241286r31","doi-asserted-by":"publisher","first-page":"E625","DOI":"10.1503\/cmaj.161020","article-title":"Use of antibiotics during pregnancy and risk of spontaneous abortion.","volume":"189","author":"Muanda","year":"2017","journal-title":"CMAJ"},{"issue":"19","key":"zoi241286r33","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1002\/bdr2.1409","article-title":"Maternal genitourinary infections and risk of birth defects in the National Birth Defects Prevention Study.","volume":"110","author":"Howley","year":"2018","journal-title":"Birth Defects Res"},{"issue":"1","key":"zoi241286r34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/14034940210134194","article-title":"Predictive value and completeness of the registration of congenital abnormalities in three Danish population-based registries.","volume":"31","author":"Larsen","year":"2003","journal-title":"Scand J Public Health"},{"key":"zoi241286r35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2147\/CLEP.S15627","article-title":"Children diagnosed with congenital cardiac malformations at the national university departments of pediatric cardiology: positive predictive values of data in the Danish National Patient Registry.","volume":"3","author":"Agergaard","year":"2011","journal-title":"Clin Epidemiol"},{"key":"zoi241286r2","unstructured":"Public Health Agency of Sweden; Swedish Medical Products Agency; Strama. Treatment recommendations for common infections in outpatient care. Accessed March 15, 2024. https:\/\/www.folkhalsomyndigheten.se\/contentassets\/246aa17721b44c5380a0117f6d0aba40\/behandlingsrekommendationer-oppenvard.pdf"},{"key":"zoi241286r20","unstructured":"World Health Organization. International Clearinghouse for Birth Defects Monitoring Systems. Birth defects surveillance: a manual for programme managers, 2nd ed. December 1, 2020. Accessed October 10, 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240015395"},{"key":"zoi241286r21","unstructured":"EUROCAT. EUROCAT Guide 1.5: Instruction for the registration of congenital anomalies. 2022. Accessed October 10, 2024. https:\/\/eu-rd-platform.jrc.ec.europa.eu\/eurocat\/data-collection\/guidelines-for-data-registration_en"},{"key":"zoi241286r24","unstructured":"Dead? AG, Soe? MM, Sullivan? KM. OpenEpi: open source epidemiologic statistics for public health, version 3.01. 2013. Accessed November 30, 2023. https:\/\/www.openepi.com\/Power\/PowerCohort.htm"},{"key":"zoi241286r28","unstructured":"R Core Team. R: A language and environment for statistical computing. 2022. Accessed October 10, 2024. https:\/\/www.R-project.org\/"},{"key":"zoi241286r32","unstructured":"EUROCAT Network. Prenatal detection rates charts 2017-2021. Accessed March 14, 2024. https:\/\/eu-rd-platform.jrc.ec.europa.eu\/eurocat\/eurocat-data\/prenatal-screening-and-diagnosis_en?a=4#filter"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2826169\/nakitanda_2024_oi_241286_1730921778.78707.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T11:00:57Z","timestamp":1731582057000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2826169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11,4]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.45055","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]}}}